Articles
Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa
Pediatr Dermatol. 2023 Oct 12. doi: 10.1111/pde.15440. Epub ahead of print. PMID: 37827535. Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis […]Assessing the epidemiological factors of epidermolysis bullosain Shiraz, the referral center of Southern Iran
JCIMCR Assessing the epidemiological factors of epidermolysis bullosain Shiraz, the referral center of Southern Iran Authors: Ali Akbar Mohammadi1,2; Nasrin Saki3,4; Mohammad Mahdi Parvizi4, Amir Hossein […]Epidermolysis bullosa: time to come together for better outcomes
Br J Dermatol. 2023 Jul 7;189(1):5. doi: 10.1093/bjd/ljad123. PMID: 37067920. Epidermolysis bullosa: time to come together for better outcomes Authors: Gabriela Petrof 1, Anna E Martinez 1 Affiliation: Abstract: […]Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step towards outcome harmonization
Br J Dermatol. 2023 Jul 7;189(1):80-90. doi: 10.1093/bjd/ljad077. PMID: 37098154. Heterogeneity of reported outcomes in epidermolysis bullosa clinical research: a scoping review as a first step […]BG04 Oleogel-S10 (birch triterpenes) in the treatment of epidermolysis bullosa wounds: 24-month efficacy and safety data from the EASE study
Keywords: Oleogel-S10, Amryt, AbstractABSTRACT: Compassionate use of topical beremagene geperpavec (B-VEC) for the treatment of recurrent cicatrizing conjunctivitis in a patient with dystrophic epidermolysis bullosa
Keywords: B-VEC, Krystal, Opthalmology, Gene therapyCharacterization of wound microbes in epidermolysis bullosa: A focus on Pseudomonas aeruginosa.
Keywords: epidermolysis bullosa; infection-bacterial; therapy-topical.Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype
J Dermatol. 2023 Jun;50(6):837-842. doi: 10.1111/1346-8138.16729. Epub 2023 Jan 24. PMID: 36694424. Success of dupilumab in itchy recessive dystrophic epidermolysis bullosa of non-pruriginosa subtype Authors: Xue-Ge […]Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa
Cells. 2023 May 24;12(11):1468. doi: 10.3390/cells12111468. PMID: 37296590; PMCID: PMC10252830. Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment […]A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis
JPGN Rep. 2023 Apr 26;4(2):e313. doi: 10.1097/PG9.0000000000000313. PMID: 37200727; PMCID: PMC10187860. A Case of Recessive Dystrophic Epidermolysis Bullosa Associated Colitis Authors: Katelyn McCann 1, Karen Wiss 1 2, Jeffrey Covington 3, Vanessa Laffert 1, Kerri B Gosselin 1 Affiliation: […]Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa
Biomolecules. 2023 Apr 25;13(5):740. doi: 10.3390/biom13050740. PMID: 37238610; PMCID: PMC10216840. Trametinib-Induced Epidermal Thinning Accelerates a Mouse Model of Junctional Epidermolysis Bullosa Authors: Grace Tartaglia 1, Pyung Hun Park 1, Michael […]Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management
JAAD Int. 2023 Mar 29;11:224-232. doi: 10.1016/j.jdin.2023.02.016. PMID: 37179539; PMCID: PMC10173168. Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient management Authors: […]